Physician profile
Ellen D Phillips
NPI 1487699716
$2,150.99
in general payments reported to CMS, 2019-2025
27 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $515 · 2020: $262 · 2021: $332 · 2022: $265 · 2023: $344 · 2024: $290 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $657 · Education: $119.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $657.24 |
| Education | $119.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $622.32 | 2019-2023 | |
| Astellas Pharma US INC | $313.69 | 2019-2025 | Veozah |
| Sumitomo Pharma America, INC. | $205.21 | 2023-2024 | Myfembree, Gemtesa |
| Hologic Sales and Service, LLC | $165.21 | 2019-2023 | Acessa Provu System, Coolseal Generator |
| Exeltis, USA INC. | $111.49 | 2021-2025 | Slynd |
| Scynexis, INC. | $65.74 | 2022 | |
| Sage Therapeutics, LLC | $58.46 | 2024-2025 | Zurzuvae |
| Lupin INC. | $56.37 | 2019 | |
| Therapeuticsmd, INC. | $56.30 | 2019-2021 | |
| Urovant Sciences INC | $52.78 | 2021-2022 | |
| Axonics, INC. | $43.11 | 2023 | Axonics |
| Bayer Healthcare Pharmaceuticals INC. | $42.63 | 2019-2022 | |
| Solventum Corporation | $40.92 | 2025 | Prevena |
| Daiichi Sankyo INC. | $39.75 | 2021-2022 | |
| Organon LLC | $35.61 | 2023-2024 | Nexplanon |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $35.21 | 2019-2021 | |
| Pfizer INC. | $28.93 | 2022-2023 | |
| Myovant Sciences INC. | $26.94 | 2022 | |
| Amgen INC. | $25.82 | 2020 | |
| Roche Diagnostics Corporation | $19.71 | 2019 | |
| Bard Access Systems, INC. | $19.34 | 2019 | |
| Dexcom, INC. | $18.77 | 2023 | Dexcom G6 Transmitter |
| Duchesnay USA Incorporated | $14.69 | 2019 | |
| Next Science LLC | $14.62 | 2020 | |
| Shield Therapeutics INC | $14.45 | 2023 | Accrufer |
| Medtronic, INC. | $11.94 | 2021 | |
| Avion Pharmaceuticals | $10.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ellen Phillips listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.